Lilly Profit Plunges as Cheaper Generics Take Toll
October 23, 2014 at 08:09 AM EDT
Eli Lilly said its quarterly earnings plunged 58%, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its earlier full-year profit forecast.
